{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T19:30:14Z","timestamp":1781292614675,"version":"3.54.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jchf.2024.03.022","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T14:38:12Z","timestamp":1717598292000},"page":"1487-1493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Novel Initiative Increasing GDMT Use Among Patients With Heart\u00a0Failure With Reduced Ejection Fraction"],"prefix":"10.1016","volume":"12","author":[{"given":"Andrei","family":"Minciunescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7742-9628","authenticated-orcid":false,"given":"Carolyn","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kepplinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Overbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren S.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq M.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jchf.2024.03.022_bib1","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40273-020-00952-0","article-title":"A\u00a0systematic review of medical costs associated with heart failure in the USA (2014-2020)","volume":"38","author":"Urbich","year":"2020","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10.1016\/j.jchf.2024.03.022_bib2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry","volume":"72","author":"Greene","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jchf.2024.03.022_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jchf.2016.12.018","article-title":"Early adoption of sacubitril\/valsartan for patients with heart failure with reduced ejection fraction: insights from Get With the Guidelines-Heart Failure (GWTG-HF)","volume":"5","author":"Luo","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2024.03.022_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/VHRM.S197291","article-title":"Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril\/valsartan","volume":"16","author":"Sokos","year":"2020","journal-title":"Vasc Health Risk Manag"},{"issue":"10","key":"10.1016\/j.jchf.2024.03.022_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.jchf.2024.03.022_bib6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/CIRCULATIONAHA.119.044976","article-title":"Challenges and potential improvements to patient access to pharmaceuticals: examples from cardiology","volume":"142","author":"Psotka","year":"2020","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.jchf.2024.03.022_bib7","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.jacc.2022.03.338","article-title":"Electronic alerts to improve heart failure therapy in outpatient practice: a cluster randomized trial","volume":"79","author":"Ghazi","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jchf.2024.03.022_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jama.2021.8844","article-title":"Effect of a hospital and postdischarge quality improvement intervention on clinical outcomes and quality of care for patients with heart failure with reduced ejection fraction: the CONNECT-HF randomized clinical trial","volume":"326","author":"DeVore","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jchf.2024.03.022_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jacc.2023.03.430","article-title":"Implementing guideline-directed medical therapy for heart failure: JACC focus seminar 1\/3","volume":"82","author":"Patolia","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10367","key":"10.1016\/j.jchf.2024.03.022_bib10","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.jchf.2024.03.022_bib11","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.jacc.2020.07.023","article-title":"2020 ACC\/AHA clinical performance and quality measures for adults with heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures","volume":"76","author":"Heidenreich","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jchf.2024.03.022_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005400","article-title":"Patient, provider, and practice characteristics associated with sacubitril\/valsartan use in the United States","volume":"11","author":"DeVore","year":"2018","journal-title":"Circ Heart Fail"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924004311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924004311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:15:21Z","timestamp":1762607721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177924004311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2213177924004311"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2024.03.022","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Initiative Increasing GDMT Use Among Patients With Heart\u00a0Failure With Reduced Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2024.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}